Express-evaluation of the psycho-physiological condition of Paralympic athletes
Alexander Drozdovski,1 Irina Gromova,2 Konstantin Korotkov,1 Oleg Shelkov,1 Femi Akinnagbe3
1Saint Petersburg Federal Research Institute of Physical Culture and Sport, St Petersburg, Russia; 2Paralympic Team of Russia, Moscow, Russia; 3Georgetown University, Washington, DC, USA
Objective: Evaluation of elite athletes’ psycho-physiological condition at various stages of preparation and in international competition.
Design: Athletes were tested during training and participation in international competition using methods of galvanic skin response (GSR) and gas discharge visualization (GDV).
Setting: Saint Petersburg Federal Research Institute of Physical Culture and Sport, Russia and Paralympic athletic training camp, Norway.
Participants: Eighteen athletes from Russia’s Skiing and Biathlon Paralympic Team. All athletes had some level of damage to their musculoskeletal system.
Main outcome measures: Stress level (SL), energy potential (EP), and psycho-emotional tension (PET).
Results: It was found that the higher the level of EP achieved by the athlete in the training period, the lower the SL in the competition time. The SL of an athlete recorded in the training period significantly correlates with the SL both before and at the time of competition. The PET and SL before the World Cup was negatively correlated to the results of skiing competitions.
Conclusion: Evaluation of PET, EP, and SL through GSR and GDV offers a fast, highly precise, non-invasive method to assess an athlete’s level of readiness during both training and at the time of competition.
Keywords: paralympic sport, express-analysis, galvanic skin response (GSR), gas discharge visualization (GDV)
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Readers of this article also read:
Single- and multiple-dose pharmacokinetics, pharmacodynamics, and safety of apixaban in healthy Chinese subjects [Corrigendum]
Cui Y, Song Y, Wang J, Yu Z, Schuster A, Barrett YC, Frost C
Published Date: 27 March 2014
Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers
Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T
Published Date: 19 March 2014
Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H
Published Date: 4 March 2014
Gao B, Doan A, Hybertson BM
Published Date: 3 February 2014
Published Date: 31 May 2013
Østerås H, Garnæs KK, Augestad LB
Published Date: 25 March 2013
Drury CT, Bredin SS, Phillips AA, Warburton DE
Published Date: 20 August 2012
Willis KS, Smith DT, Broughton KS, Larson-Meyer DE
Published Date: 27 April 2012
Personal best times in an Olympic distance triathlon and in a marathon predict Ironman race time in recreational male triathletes
Rüst CA, Knechtle B, Knechtle P, Rosemann T, Lepers R
Published Date: 22 August 2011
Published Date: 18 August 2011